140 related articles for article (PubMed ID: 9440504)
1. Molecular modeling of the interaction of diagnostic radiopharmaceuticals with receptor proteins: m2 antagonist binding to the muscarinic m2 subtype receptor.
Kapp OH; Siemion J; Eckelman WC; Cohen VI; Reba RC
Recept Signal Transduct; 1997; 7(3):177-201. PubMed ID: 9440504
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR.
Miyoshi S; Tu AT
Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446
[TBL] [Abstract][Full Text] [Related]
3. In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNB.
Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Knapp FF
Recept Signal Transduct; 1997; 7(1):45-54. PubMed ID: 9285530
[TBL] [Abstract][Full Text] [Related]
4. Homology modeling of human muscarinic acetylcholine receptors.
Thomas T; McLean KC; McRobb FM; Manallack DT; Chalmers DK; Yuriev E
J Chem Inf Model; 2014 Jan; 54(1):243-53. PubMed ID: 24328076
[TBL] [Abstract][Full Text] [Related]
5. Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors.
Pittel Z; Wess J
Mol Pharmacol; 1994 Jan; 45(1):61-4. PubMed ID: 8302281
[TBL] [Abstract][Full Text] [Related]
6. Antagonist binding in the rat muscarinic receptor A study by docking and X-ray crystallography.
Tanczos AC; Palmer RA; Potter BS; Saldanha JW; Howlin BJ
Comput Biol Chem; 2004 Dec; 28(5-6):375-85. PubMed ID: 15556478
[TBL] [Abstract][Full Text] [Related]
7. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
[TBL] [Abstract][Full Text] [Related]
8. In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT.
Cohen VI; Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Reba RC
J Mol Neurosci; 1998 Aug; 11(1):1-9. PubMed ID: 9826782
[TBL] [Abstract][Full Text] [Related]
9. Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding.
Vistoli G; Pedretti A; Dei S; Scapecchi S; Marconi C; Romanelli MN
Bioorg Med Chem; 2008 Mar; 16(6):3049-58. PubMed ID: 18182302
[TBL] [Abstract][Full Text] [Related]
10. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
Peng JY; Vaidehi N; Hall SE; Goddard WA
ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
[TBL] [Abstract][Full Text] [Related]
11. The conformational and property space of acetylcholine bound to muscarinic receptors: an entropy component accounts for the subtype selectivity of acetylcholine.
Vistoli G; Pedretti A; Testa B; Matucci R
Arch Biochem Biophys; 2007 Aug; 464(1):112-21. PubMed ID: 17544360
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
13. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
Bissantz C; Bernard P; Hibert M; Rognan D
Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
[TBL] [Abstract][Full Text] [Related]
14. Enantiomeric N-methyl-4-piperidyl benzilates as muscarinic receptor ligands: Radioligand binding studies and docking studies to models of the three muscarinic receptors M1, M2 and M3.
Selent J; Brandt W; Pamperin D; Göber B
Bioorg Med Chem; 2006 Mar; 14(6):1729-36. PubMed ID: 16290166
[TBL] [Abstract][Full Text] [Related]
15. Modelling of the binding site of the human m1 muscarinic receptor: experimental validation and refinement.
Bourdon H; Trumpp-Kallmeyer S; Schreuder H; Hoflack J; Hibert M; Wermuth CG
J Comput Aided Mol Des; 1997 Jul; 11(4):317-32. PubMed ID: 9334899
[TBL] [Abstract][Full Text] [Related]
16. Structure-function studies of muscarinic acetylcholine receptors.
Leach K; Simms J; Sexton PM; Christopoulos A
Handb Exp Pharmacol; 2012; (208):29-48. PubMed ID: 22222693
[TBL] [Abstract][Full Text] [Related]
17. Site-directed mutagenesis of the putative human muscarinic M2 receptor binding site.
Heitz F; Holzwarth JA; Gies JP; Pruss RM; Trumpp-Kallmeyer S; Hibert MF; Guenet C
Eur J Pharmacol; 1999 Sep; 380(2-3):183-95. PubMed ID: 10513578
[TBL] [Abstract][Full Text] [Related]
18. Allosteric binding sites on muscarinic acetylcholine receptors.
Wess J
Mol Pharmacol; 2005 Dec; 68(6):1506-9. PubMed ID: 16183853
[TBL] [Abstract][Full Text] [Related]
19. Conformational analysis and receptor modelling of m1 and m2 selective antagonists.
Kerckhoff H; Höltje HD
Pharmazie; 1994 Aug; 49(8):566-73. PubMed ID: 7938144
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of human m1 muscarinic acetylcholine receptors with double mutations at the junction of TM VI and the third extracellular domain.
Huang XP; Williams FE; Peseckis SM; Messer WS
J Pharmacol Exp Ther; 1998 Sep; 286(3):1129-39. PubMed ID: 9732369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
